Humanized anti-human NKG2A monoclonal antibody

Details for Australian Patent Application No. 2009207644 (hide)

Owner Novo Nordisk A/S

Inventors Jing, Su; Padkjaer, Soren Berg; Spee, Petrus Johannes Louis; Chen, Jianhe; Zhang, Jinchao; Yu, Jiujiu

Agent Shelston IP

Pub. Number AU-A-2009207644

PCT Pub. Number WO2009/092805

Priority 08150601.6 24.01.08 EP

Filing date 23 January 2009

Wipo publication date 30 July 2009

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

22 July 2010 PCT application entered the National Phase

  PCT publication WO2009/092805 Priority application(s): WO2009/092805

12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009207645-Selective exosite inhibition of PAPP-A activity against IGFBP-4

2009207638-Object comprising a graphics element transferred onto a support wafer and method of producing such an object